TY - JOUR
T1 - The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice
AU - Sonsalla, Patricia K.
AU - Heikkila, Richard E.
N1 - Funding Information:
This research was supported by grants from the NIH, the American Parkinson Disease Association, the United Parkinson Foundation, and the Smokeless Tobacco Research Council.
PY - 1986/10/7
Y1 - 1986/10/7
N2 - The effects of different dosing paradigms for the administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) were investigated in C57-black and CF-W albino mice. Several groups of mice received a total dose of 80 mg/kg of MPTP administered at different doses per injection and/or at different time intervals. In C57-black mice, the effects of MPTP administration on the neostriatal content of dopamine ranged from a 91% depletion (4 injections of 20 mg/kg per injection at 1 h intervals) to a non-significant effect (4 injections of 10 mg/kg per injection at 2 h intervals on each of 2 successive days). There was also considerable influence of the MPTP dose per injection and the dosing interval in CF-W mice, although the extent of neostriatal dopamine depletion in CF-W mice was not as great as that observed in C57-black mice. In addition, MPTP produced variable effects on neostriatal dopamine levels in different strains of mice as well as in Swiss-Webster mice obtained from different sources. Some of the strains were affected to a great extent while others were only marginally affected.
AB - The effects of different dosing paradigms for the administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) were investigated in C57-black and CF-W albino mice. Several groups of mice received a total dose of 80 mg/kg of MPTP administered at different doses per injection and/or at different time intervals. In C57-black mice, the effects of MPTP administration on the neostriatal content of dopamine ranged from a 91% depletion (4 injections of 20 mg/kg per injection at 1 h intervals) to a non-significant effect (4 injections of 10 mg/kg per injection at 2 h intervals on each of 2 successive days). There was also considerable influence of the MPTP dose per injection and the dosing interval in CF-W mice, although the extent of neostriatal dopamine depletion in CF-W mice was not as great as that observed in C57-black mice. In addition, MPTP produced variable effects on neostriatal dopamine levels in different strains of mice as well as in Swiss-Webster mice obtained from different sources. Some of the strains were affected to a great extent while others were only marginally affected.
KW - Dopamine
KW - MPTP
KW - Mouse
KW - Nigrostriatal dopaminergic neurons
KW - Strain differences
UR - http://www.scopus.com/inward/record.url?scp=0022480636&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022480636&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(86)90444-9
DO - 10.1016/0014-2999(86)90444-9
M3 - Article
C2 - 3490988
AN - SCOPUS:0022480636
SN - 0014-2999
VL - 129
SP - 339
EP - 345
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 3
ER -